Candriam SCA’s Apellis Pharmaceuticals APLS Stock Holding History

Candriam SCA’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-159,054	Closed	-$3.48M	–	681
2025 Q1	$3.48M	Sell	159,054 -380,548	-71%	-$8.32M	0.02%	400
2024 Q4	$17.2M	Sell	539,602 -140,456	-21%	-$4.48M	0.1%	189
2024 Q3	$19.6M	Buy	680,058 +137,023	+25%	+$3.95M	0.11%	182
2024 Q2	$20.8M	Sell	543,035 -41,890	-7%	-$1.61M	0.13%	162
2024 Q1	$34.4M	Buy	584,925 +247,418	+73%	+$14.5M	0.22%	110
2023 Q4	$20.2M	Buy	337,507 +11,000	+3%	+$658K	0.14%	158
2023 Q3	$12.4M	Hold	326,507	–	–	0.09%	204
2023 Q2	$29.7M	Sell	326,507 -117,000	-26%	-$10.7M	0.22%	119
2023 Q1	$26.9M	Buy	443,507 +165,000	+59%	+$10M	0.19%	133
2022 Q4	$14.4M	Sell	278,507 -65,000	-19%	-$3.36M	0.1%	211
2022 Q3	$23.5M	Sell	343,507 -271,950	-44%	-$18.6M	0.17%	139
2022 Q2	$27.8M	Buy	615,457 +149,362	+32%	+$6.75M	0.23%	104
2022 Q1	$23.7M	Sell	466,095 -228,330	-33%	-$11.6M	0.16%	141
2021 Q4	$32.8M	Buy	694,425 +439,395	+172%	+$20.8M	0.21%	123
2021 Q3	$8.41M	Sell	255,030 -62,285	-20%	-$2.05M	0.06%	305
2021 Q2	$20.1M	Sell	317,315 -238,059	-43%	-$15M	0.14%	174
2021 Q1	$30.5M	Hold	555,374	–	–	0.25%	103
2020 Q4	$31.8M	Sell	555,374 -593,491	-52%	-$33.9M	0.25%	103
2020 Q3	$34.7M	Sell	1,148,865 -61,533	-5%	-$1.86M	0.33%	69
2020 Q2	$39.5M	Buy	1,210,398 +818,198	+209%	+$26.7M	0.42%	50
2020 Q1	$11.7M	Hold	392,200	–	–	0.13%	182
2019 Q4	$12M	Sell	392,200 -42,500	-10%	-$1.3M	0.13%	184
2019 Q3	$10.5M	Sell	434,700 -93,000	-18%	-$2.24M	0.14%	175
2019 Q2	$13.3M	Hold	527,700	–	–	0.17%	144
2019 Q1	$10.3M	Hold	527,700	–	–	0.13%	181
2018 Q4	$6.96M	Buy	527,700 +12,000	+2%	+$158K	0.11%	220
2018 Q3	$9.17M	Buy	515,700 +275,700	+115%	+$4.9M	0.12%	202
2018 Q2	$5.28M	Buy	240,000 +116,000	+94%	+$2.55M	0.08%	285
2018 Q1	$2.74M	Buy	124,000 +7,000	+6%	+$155K	0.05%	411
2017 Q4	$2.54M	Buy	+117,000	New	+$2.54M	0.04%	410